Page last updated: 2024-10-30

mazindol and Carcinoma 256, Walker

mazindol has been researched along with Carcinoma 256, Walker in 1 studies

Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.

Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
" The results obtained by dosage of d-amphetamine, fenfluramine or mazindol, on days 5 and 8 after tumor implantation, failed to demonstrate conclusively any predominant modification of a dopaminergic, noradrenergic, or serotonergic system in the anorectic effects of these agents."1.27Effects of anorectic agents in rats bearing the Walker-256 tumor. ( Johnson, K; Kinney, DR; Maickel, RP, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maickel, RP1
Johnson, K1
Kinney, DR1

Other Studies

1 other study available for mazindol and Carcinoma 256, Walker

ArticleYear
Effects of anorectic agents in rats bearing the Walker-256 tumor.
    Research communications in chemical pathology and pharmacology, 1987, Volume: 58, Issue:3

    Topics: Animals; Appetite Depressants; Biogenic Amines; Carcinoma 256, Walker; Dextroamphetamine; Eating; Fe

1987